Neximmune Inc reports results for the quarter ended in December - Earnings Summary

Neximmune

28/03/2023 22:10

* Neximmune Inc  NEXI.OQ  reported a quarterly adjusted loss
of 70
cents​​ per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss
of 51 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Neximmune Inc's reported EPS for the quarter was a loss
of 70
cents​.
    * The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Neximmune Inc shares had risen by 62.5% this quarter.
    * The company reported a quarterly loss of $16.89 million.
    * Wall Street's median 12-month price target for Neximmune
Inc is
$3.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 09:10 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.51          -0.70          Missed
 Sep. 30 2022      -0.69          -0.60          Beat
 Jun. 30 2022      -0.68          -0.69          Missed
 Mar. 31 2022      -0.70          -0.66          Beat